dronabinol

FDA Drug Profile — DRONABINOL

dronabinol is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including DRONABINOL. Available dosage form: capsule.

Drug details

Generic Name
dronabinol
Brand Names
DRONABINOL
Application Number
ANDA207421
Sponsor
Camber Pharmaceuticals Inc
NDC Codes
3
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
DRONABINOL

Indications and Usage

1 INDICATIONS AND USAGE Dronabinol capsules are indicated in adults for the treatment of: • anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS). • nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Dronabinol capsules is a cannabinoid indicated in adults for the treatment of: • Anorexia associated with weight loss in patients with AIDS. ( 1 ) • Nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.